Close Menu

The British government has given its approval for the creation of a £30 million stem cell therapy center, part of a £220 million program to turn British stem cell researchers' discoveries into "a new multimillion-pound industry to help drive Britain's recovery," reports the Guardian's Rupert Neate. The stem cell center, which is slated to open in April 2012, will take advantage of the UK's leadership in stem cell research, Neate says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.